Clin2
NCT07716956Possibly a fitRecruiting

Magnesium therapy for severe septic shock

Septic ShockSepsis

Treatments studied

Part of Infections clinical trials.

This trial tests whether raising magnesium levels in the blood to a normal upper range can help reduce the need for strong blood pressure medications in people with severe septic shock. It might help stabilize blood pressure and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with septic shock.
  • Your septic shock is resistant to standard treatment and requires corticosteroids.
  • You are not pregnant.
  • Your baseline magnesium level is not above 2.3 mg/dL.
  • Your kidney function is not severely impaired (creatinine clearance is at least 10 ml/min).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07052084Not yet recruiting· Phase 3
Adding vasopressin to standard treatment for septic shock

This trial tests whether adding vasopressin (a hormone that narrows blood vessels) to usual care can improve recovery in patients with septic shock (a severe infection causing very low blood pressure). If you are already on a strong blood pressure medication, this study may help stabilize your condition.

Marseille
NCT07711197Not yet recruiting
Blood filter treatment for septic shock

This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.

Budapest
NCT06366854Not yet recruiting
A new treatment approach for septic shock

This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.

NCT06634069Recruiting· Phase 2
Testing a new approach for septic shock patients

This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.

Pilsen, Czech Republic
NCT06749756Recruiting
Vitamins B6, B12 and C for sepsis

This trial tests whether a combination of vitamins B6, B12, and C can help improve blood flow in tiny blood vessels (microcirculation) for people with sepsis. It may help your body recover better from severe infection.

Chengdu, Sichuan
NCT07698093Not yet recruiting
Monitoring immune function during septic shock

This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.

Lyon

Hear when a new Septic Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.